Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;37(8):1927-33.
doi: 10.1007/s00268-013-2051-4.

The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients

Affiliations

The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients

Yen-Jung Lu et al. World J Surg. 2013 Aug.

Abstract

Background: The prognostic value of nodal status in colorectal cancer (CRC) patients may be influenced by the total number of lymph nodes (LNs) harvested. This study evaluates the impact of LN ratio (LNR) on CRC patients' outcome.

Methods: A total of 612 stage III CRC patients who underwent curative-intent surgery between 2004 and 2008 were enrolled. The measured end point was postoperative disease-free survival (DFS) and overall survival (OS).

Results: The metastatic LN numbers were significantly higher in patients with more than 12 LN harvested (4.6 ± 5.81 vs. 2.7 ± 1.97, P < 0.001). The mean LNR was 22.9 ± 20 % (range = 2-100 %, median = 16.7 %). As the cutoff value of LNR was set above 17 %, the impact of the LNR on 5-year DFS became statistically significant. In univariate analysis, the 5-year DFS and OS for patients with high-LNR tumors was 54.4 and 57.3 %, respectively, significantly lower than those for patients with low-LNR tumors (72.8 and 76.4 %; P < 0.001). In multivariate analysis, the independent factors affecting the 5-year DFS and OS were tumor depth, carcinoembryonic antigen level, and LNR.

Conclusion: The LNR, set at the median value or 17 %, could be an independent prognostic factor for stage III CRC patients.

PubMed Disclaimer

References

    1. J Natl Cancer Inst. 2005 Feb 2;97(3):219-25 - PubMed
    1. Am Surg. 2004 Mar;70(3):235-40; discussion 240 - PubMed
    1. Am J Clin Pathol. 1996 Aug;106(2):209-16 - PubMed
    1. J Clin Oncol. 2005 Dec 1;23(34):8706-12 - PubMed
    1. J Natl Cancer Inst. 2007 Mar 21;99(6):433-41 - PubMed